Relationship between ABO Blood Group and COVID-19: The Case of Siirt

Basit Öğe Kaydı
dc.authoridOzudogru, Osman/0000-0003-1212-2251
dc.contributor.authorUyuklu, Mehmet
dc.contributor.authorOzudogru, Osman
dc.date.accessioned2024-12-24T19:30:01Z
dc.date.available2024-12-24T19:30:01Z
dc.date.issued2020
dc.departmentSiirt Üniversitesi
dc.description.abstractObjective: Epidemiological and clinical studies have shown that age and chronic diseases are important risk factors in the mortality of patients infected by Coronavirus disease 2019 (COVID-19). However, there is no biomarker identified yet for susceptibility to the disease. Some studies have reported that ABO blood groups are associated with a predisposition to Covid-19. In this study, it was aimed to investigate the relationship between ABO blood groups and COVID-19 susceptibility in Siirt province scale. Methods: In this study, the blood groups of 174 patients, all of whom were in Siirt, were confirmed retrospectively at the Siirt State Hospital, all confirmed by revers-transcriptase chain reaction. For comparison, data from 36394 patients whose blood group was detected in the Siirt State Hospital were used. Results: In Siirt provincial normal population; while blood groups A, B, AB and O were 40%, 19.5%, 8.5% and 32% respectively, the blood groups of COVID-19 positive patients were 42.5%, 19.5%, 8%, and 30%. No statistically significant difference was found in blood group distribution rates between healthy and COVID-19 patient groups (>0.05). The distribution of blood group rates of patients hospitalized in the intensive care unit was not different from healthy individuals (>0.05). No significant difference could be calculated between the duration of hospitalization in the intensive care unit and blood groups. Conclusion: As a result, unlike studies showing that the risk of COVID-19 infection was higher in the A blood group and lower in the O blood group, no relationship was found between the blood group and the risk of COVID-19 infection and intensive care therapy. Combining the results of this study with data from other regions, it is thought that only if the relationship between blood group COVID-19 can be confirmed, it may be a guide for diagnosis, follow-up and treatment.
dc.identifier.doi10.14235/bas.galenos.2020.5000
dc.identifier.endpage40
dc.identifier.issn2148-2373
dc.identifier.startpage36
dc.identifier.trdizinid419181
dc.identifier.urihttps://doi.org/10.14235/bas.galenos.2020.5000
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/419181
dc.identifier.urihttps://hdl.handle.net/20.500.12604/7337
dc.identifier.volume8
dc.identifier.wosWOS:000613755400007
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakTR-Dizin
dc.language.isoen
dc.publisherGalenos Publ House
dc.relation.ispartofBezmialem Science
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_20241222
dc.subjectCOVID-19
dc.subjectblood group
dc.subjectcorona virus
dc.subjectSiirt
dc.titleRelationship between ABO Blood Group and COVID-19: The Case of Siirt
dc.typeArticle

Dosyalar

Koleksiyon

WOS İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu